Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | |
| Operating Expenses | 4,211 | 0 | 2,332 |
| Operating Income | -4,211 | N/A | -2,332 |
| Other Income | 2 | 0 | -7 |
| Pre-tax Income | -4,209 | 0 | -2,339 |
| Net Income Continuous | -4,209 | N/A | -2,339 |
| Net Income | $-4,209 | $N/A | $-2,339 |
| EPS Basic Total Ops | -2.09 | N/A | -1.47 |
| EPS Basic Continuous Ops | -2.10 | N/A | -1.47 |
| EPS Diluted Total Ops | -2.09 | N/A | -1.47 |
| EPS Diluted Continuous Ops | -2.10 | N/A | -1.47 |
| EBITDA(a) | $-4,189 | $N/A | $-2,332 |